Century Therapeutics, Inc.
IPSC
$1.92
-$0.01-0.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 119.71M | 134.80M | 117.11M | 132.75M | 155.84M |
| Total Receivables | 1.48M | 1.37M | 667.00K | 484.00K | 626.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.58M | 2.51M | 520.00K | 3.63M | 3.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 350.00K | 2.47M | 845.00K | -- |
| Total Current Assets | 124.77M | 139.04M | 120.77M | 137.71M | 160.17M |
|
|
|||||
| Total Current Assets | 124.77M | 139.04M | 120.77M | 137.71M | 160.17M |
| Net Property, Plant & Equipment | 48.00M | 68.58M | 66.17M | 70.28M | 84.39M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 34.20M | 34.20M | 34.20M | 34.20M | 34.20M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.57M | 2.57M | 2.57M | 2.53M | 3.25M |
| Total Assets | 287.01M | 326.55M | 223.70M | 244.72M | 284.69M |
|
|
|||||
| Total Accounts Payable | 4.82M | 3.15M | 4.77M | 2.62M | 3.21M |
| Total Accrued Expenses | 6.21M | 4.39M | 8.35M | 7.28M | 6.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.04M | 4.08M | 3.32M | 3.77M | 4.89M |
| Total Finance Division Other Current Liabilities | -- | 1.94M | 3.78M | 8.36M | 20.00K |
| Total Other Current Liabilities | -- | 1.94M | 3.78M | 8.36M | 20.00K |
| Total Current Liabilities | 15.07M | 13.57M | 20.23M | 22.03M | 14.95M |
|
|
|||||
| Total Current Liabilities | 15.07M | 13.57M | 20.23M | 22.03M | 14.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 34.63M | 43.94M | 40.24M | 41.19M | 46.59M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.97M | 4.30M | 4.30M | 5.16M | 13.26M |
| Total Liabilities | 54.66M | 61.81M | 64.77M | 68.37M | 74.79M |
|
|
|||||
| Common Stock & APIC | 1.08B | 1.08B | 950.82M | 949.02M | 948.13M |
| Retained Earnings | -848.11M | -813.56M | -791.92M | -772.74M | -738.32M |
| Treasury Stock & Other | -694.00K | -585.00K | 30.00K | 64.00K | 83.00K |
| Total Common Equity | 232.35M | 264.74M | 158.94M | 176.35M | 209.90M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 232.35M | 264.74M | 158.94M | 176.35M | 209.90M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 232.35M | 264.74M | 158.94M | 176.35M | 209.90M |
|
|
|||||